Changes

Jump to navigation Jump to search
Line 83: Line 83:     
======Serology======
 
======Serology======
  −
    A combination of complement fixation (CF), haemagglutination inhibition (HAI) and cross-serum neutralization assays supports the acquisition of a positive diagnosis. Serological confirmation of EEE or WEE virus infection requires a four-fold or greater increase or decrease in antibody titre in paired serum samples collected 10-14 days apart. Most horses infected with EEE and WEE virus have a high antibody titre when clinical disease is observed. Horses infected with EEE or WEE virus usually have antibody titres in the acute stage of the disease. Consequently, a presumptive diagnosis can be made if an unvaccinated horse with appropriate clinical signs has antibody against only EEE or WEE virus. The detection of IgM antibody by the ELISA can also provide a presumptive diagnosis of acute infection (11). The plaque reduction neutralisation (PRN) test or, preferably, a combination of PRN and haemagglutination inhibition (HI) tests is the procedure most commonly used for the detection of antibody against EEE and WEE viruses. There are cross-reactions between antibody against EEE and WEE virus in the CF and HI tests. CF antibody against both EEE and WEE viruses appears later and does not persist; consequently, it is less useful for the serological diagnosis of disease.
  −
  −
A 4-fold increase in antibody (Ab) titre in convlescent sera is quoted for diagnosis but this test lacks sensitivity.  The presence of viral Abs within 24hours of the initial viraemia typically precedes clinical signs.  Ab titre increases sharply then deteriorates over 6 months.  Samples taken when clinical signs appear are likely to miss the Ab peak and may thus demonstrate a decreasing titre.  A single sample demonstrating an increased titre using HAI, CF and neutralizing Ab can provide a presumptive diagnosis.  Maternal-derived Ab may interfere with diagnosis in foals.  The serum half-life of colostral Ab in foals is around 20days.
      +
The presence of viral Abs within 24hours of the initial viraemia typically precedes clinical signs.  Ab titre increases sharply then deteriorates over 6 months.  Samples taken when clinical signs appear are likely to miss the Ab peak and may thus demonstrate a decreasing titre.  Serological confirmation of EEE or WEE virus infection requires a four-fold or greater increase or decrease in antibody titre in paired serum samples collected 10-14 days apart.  A presumptive diagnosis can be made on a single sample if an unvaccinated horse with appropriate clinical signs has antibody against only EEE or WEE virus.  Maternal-derived Ab may interfere with diagnosis in foals.  The serum half-life of colostral Ab in foals is around 20days.
 
   
 
   
*Complement fixation: to avoid anti-complementary effects, sera should be separated from the blood as soon as possible.  
+
*Complement fixation (CF): to avoid anti-complementary effects, sera should be separated from the blood as soon as possible.  
*Haemagglutination inhibition: titres of 1/10 and 1/20 are suspect, titres of 1/40 and above are positive.
+
*Haemagglutination inhibition (HAI): titres of 1/10 and 1/20 are suspect, titres of 1/40 and above are positive.
 
*ELISA may be used to detect viral-specific IgM to the surface glycoprotein of Venezuelan EEV, from 3 days post-onset of clinical signs up to 21 days post-infection.  This is useful in acute infections where convalescent serum samples are unobtainable.   
 
*ELISA may be used to detect viral-specific IgM to the surface glycoprotein of Venezuelan EEV, from 3 days post-onset of clinical signs up to 21 days post-infection.  This is useful in acute infections where convalescent serum samples are unobtainable.   
 
*The PRN test is very specific and can be used to differentiate between EEE and WEE infections.  It is performed in duck embryo fibroblast, Vero, or BHK-21 cell cultures.  Serum used in the PRN assay is tested against 100 plaque-forming units of virus.  Endpoints are based on a 90% reduction in the number of plaques compared with the virus control flasks.
 
*The PRN test is very specific and can be used to differentiate between EEE and WEE infections.  It is performed in duck embryo fibroblast, Vero, or BHK-21 cell cultures.  Serum used in the PRN assay is tested against 100 plaque-forming units of virus.  Endpoints are based on a 90% reduction in the number of plaques compared with the virus control flasks.
 +
 +
The PRN test or, preferably, a combination of PRN and HAI tests is the procedure most commonly used for the detection of Ab against Eastern and Western EEV. There are cross-reactions between Ab against bith viruses in the CF and HAI tests.CF Ab against both viruses appears later and does not persist; thus, it is less useful for serological diagnosis.
    
======Clinical Pathology======
 
======Clinical Pathology======
1,406

edits

Navigation menu